{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:02:40Z","timestamp":1790017360008,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202301ZYTS516"],"award-info":[{"award-number":["YDZJ202301ZYTS516"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110511","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T06:01:22Z","timestamp":1687154482000},"page":"110511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats"],"prefix":"10.1016","volume":"121","author":[{"given":"Jiwen","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-260X","authenticated-orcid":false,"given":"Yuquan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.intimp.2023.110511_b0005","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.intimp.2023.110511_b0010","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur. J. Preventive Cardiol."},{"key":"10.1016\/j.intimp.2023.110511_b0015","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.2147\/JIR.S370483","article-title":"The NLRP3 inflammasome as a novel therapeutic target for cardiac fibrosis","volume":"15","author":"Fan","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.110511_b0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2023.110511_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107511","article-title":"Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis","volume":"209","author":"Pinar","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2023.110511_b0030","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective","volume":"469","author":"Sandanger","year":"2016","journal-title":"Biochem. Biophys. Research Commun."},{"issue":"12","key":"10.1016\/j.intimp.2023.110511_b0035","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jacbts.2020.09.013","article-title":"Absence of NLRP3 inflammasome in hematopoietic cells reduces adverse remodeling after experimental myocardial infarction","volume":"5","author":"Louwe","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.intimp.2023.110511_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.04.022","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction","volume":"74","author":"Gao","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110511_b0045","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","article-title":"Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-\u03baB and Notch1 pathways","volume":"20","author":"An","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.intimp.2023.110511_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153398","article-title":"Celastrol ameliorates Propionibacterium acnes\/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3","volume":"80","author":"Yan","year":"2021","journal-title":"Phytomed.: Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.intimp.2023.110511_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102134","article-title":"The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2023.110511_b0060","article-title":"Permanent ligation of the left anterior descending coronary artery in mice: a model of post-myocardial infarction remodelling and heart failure","volume":"94","author":"Muthuramu","year":"2014","journal-title":"J. Visualized Experiments: JoVE"},{"issue":"8","key":"10.1016\/j.intimp.2023.110511_b0065","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","article-title":"Celastrol attenuates angiotensin II-induced cardiac remodeling by targeting STAT3","volume":"126","author":"Ye","year":"2020","journal-title":"Circulation Res."},{"issue":"23","key":"10.1016\/j.intimp.2023.110511_b0070","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1111\/bph.12838","article-title":"Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1","volume":"171","author":"Der Sarkissian","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110511_b0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2018.11.002","article-title":"Celastrol ameliorates inflammatory pain and modulates HMGB1\/NF-\u03baB signaling pathway in dorsal root ganglion","volume":"692","author":"Zhang","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2023.110511_b0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2023.110511_b0085","article-title":"Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: Current knowledge and clinical significance","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother. = Biomedecine & pharmacotherapie"},{"issue":"3","key":"10.1016\/j.intimp.2023.110511_b0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","article-title":"Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction","volume":"71","author":"Thackeray","year":"2018","journal-title":"J. Am. College Cardiol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110511_b0095","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1002\/jcp.29732","article-title":"The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction","volume":"235","author":"Liu","year":"2020","journal-title":"J. Cellular Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110511_b0100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.120.318149","article-title":"Myofibroblast deficiency of LSD1 alleviates TAC-induced heart failure","volume":"129","author":"Huo","year":"2021","journal-title":"Circulation Res."},{"key":"10.1016\/j.intimp.2023.110511_b0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2023.110511_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664457","article-title":"Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction","volume":"12","author":"Kologrivova","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110511_b0115","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cellular Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.110511_b0120","article-title":"Inflammasomes and fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110511_b0125","first-page":"27460","article-title":"Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4\/6-IRAK4\/1 signaling to suppress NLRP3 inflammasome activation","volume":"6","author":"Kang","year":"2016","journal-title":"Sci. Reports"},{"issue":"28","key":"10.1016\/j.intimp.2023.110511_b0130","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1074\/jbc.M114.550624","article-title":"Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome","volume":"289","author":"Bracey","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2023.110511_b0135","doi-asserted-by":"crossref","first-page":"e1847","DOI":"10.1038\/cddis.2015.206","article-title":"Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1\/TLR4\/NF\u03baB\/IL-1\u03b2 signaling","volume":"6","author":"Zhang","year":"2015","journal-title":"Cell Death Disease"},{"key":"10.1016\/j.intimp.2023.110511_b0140","article-title":"Colchicine prevents atrial fibrillation promotion by inhibiting IL-1\u03b2-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model","volume":"129","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother. = Biomedecine & pharmacotherapie"},{"issue":"2","key":"10.1016\/j.intimp.2023.110511_b0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00395-019-0719-0","article-title":"Blocking the IL-1\u03b2 signalling pathway prevents chronic viral myocarditis and cardiac remodeling","volume":"114","author":"Kraft","year":"2019","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110511_b0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4049\/jimmunol.176.1.603","article-title":"NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription","volume":"176","author":"Lee","year":"2006","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"37","key":"10.1016\/j.intimp.2023.110511_b0155","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.0706378104","article-title":"T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production","volume":"104","author":"Hayashi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2023.110511_b0160","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopha.2018.07.031","article-title":"Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion","volume":"106","author":"Liang","year":"2018","journal-title":"Biomed. Pharmacother. = Biomedecine & pharmacotherapie"},{"issue":"1","key":"10.1016\/j.intimp.2023.110511_b0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","article-title":"IL-18 cleavage triggers cardiac inflammation and fibrosis upon \u03b2-adrenergic insult","volume":"39","author":"Xiao","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2023.110511_b0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-319-41334-1_12","article-title":"Celastrol and its role in controlling chronic diseases","volume":"928","author":"Venkatesha","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2023.110511_b0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2018.00104","article-title":"A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110511_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107879","article-title":"Celastrol inhibits rheumatoid arthritis through the ROS-NF-\u03baB-NLRP3 inflammasome axis","volume":"98","author":"Jing","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110511_b0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jep.2012.09.005","article-title":"Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats","volume":"144","author":"Zhang","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110511_b0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2014.06.019","article-title":"Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation","volume":"472","author":"Qi","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.intimp.2023.110511_b0195","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/antiox11081597","article-title":"Celastrol: A promising agent fighting against cardiovascular diseases","volume":"11","author":"Li","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.intimp.2023.110511_b0200","doi-asserted-by":"crossref","unstructured":"R. Casc\u00e3o, T. Carvalho, J. Goncalves, L.F. Moita, J. Fonseca, AB0096 Efficacy and safety of oral administration of pure celastrol in aia rats, 2017.","DOI":"10.1136\/annrheumdis-2017-eular.2868"},{"issue":"6","key":"10.1016\/j.intimp.2023.110511_b0205","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3892\/or.2014.3535","article-title":"Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9","volume":"32","author":"Mi","year":"2014","journal-title":"Oncol. Reports"},{"issue":"9","key":"10.1016\/j.intimp.2023.110511_b0210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/boc.201300021","article-title":"Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis","volume":"105","author":"Chakravarthy","year":"2013","journal-title":"Biol. Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:05:38Z","timestamp":1761588338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923008342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"alternative-id":["S1567576923008342"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110511","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110511"}}